CIA
KRTX

Capital Impact Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Capital Impact Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,279
Closed -$494K – 172
2023
Q2 		$494K Buy
2,279
+136
+6% +$29.5K 0.54% 86
2023
Q1 		$389K Buy
+2,143
New +$389K 0.48% 95